openPR Logo
Press release

Alzheimer's Disease Diagnostic Market Projected to Reach Nearly US$ 8.07 Billion by 2030, Growing at a CAGR of 12.8%

06-27-2024 12:17 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: MAXIMIZE MARKET RESEARCH PVT. LTD.

๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ ๐Œ๐š๐ซ๐ค๐ž๐ญ

๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ ๐Œ๐š๐ซ๐ค๐ž๐ญ

๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ฌ๐ก๐š๐ซ๐ž ๐ข๐ง 2023 ๐ฐ๐š๐ฌ ๐ž๐ฌ๐ญ๐ข๐ฆ๐š๐ญ๐ž๐ ๐š๐ฌ 3.47 ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐”๐’๐ƒ.

๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‚๐€๐†๐‘ ๐„๐ฌ๐ญ๐ข๐ฆ๐š๐ญ๐ข๐จ๐ง:

The Alzheimer's Disease Diagnostic Market was valued at $3.47 billion in 2023. It is projected to grow at a robust compound annual growth rate (CAGR) of 12.8% from 2024 to 2030, reaching approximately $8.07 billion by the end of the forecast period. This significant growth rate reflects the increasing demand and advancements in diagnostic technologies.

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐˜๐จ๐ฎ๐ซ ๐…๐ซ๐ž๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐จ๐ฐ: https://www.maximizemarketresearch.com/request-sample/116921/

๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐จ๐ซ ๐‚๐ก๐š๐ง๐ ๐ž๐ฌ ๐ข๐ง ๐ƒ๐ž๐ฆ๐š๐ง๐: ๐–๐ก๐š๐ญ'๐ฌ ๐„๐ฑ๐ฉ๐ž๐œ๐ญ๐ž๐?

The market for Alzheimer's disease diagnostics is experiencing substantial growth, driven primarily by the rising prevalence of Alzheimer's and other dementia-related diseases. In 2022, around 50 million people globally were reported to have Alzheimer's, with expectations for this number to reach 152 million by 2050. This surge is pushing the demand for early diagnostic tools and effective treatment options.

๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ:

Alzheimer's disease is the most prevalent form of dementia, characterized by progressive memory loss and cognitive decline. The disease primarily affects parts of the brain that control thought and language. While there is no cure, certain medications can temporarily alleviate symptoms. The market is driven by increasing chronic diseases, investments in biomarker research, and the development of sophisticated diagnostic treatments.

๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐œ๐จ๐ฉ๐ž ๐š๐ง๐ ๐Œ๐ž๐ญ๐ก๐จ๐๐จ๐ฅ๐จ๐ ๐ฒ:

The scope of the Alzheimer's Disease Diagnostic Market includes a comprehensive analysis of diagnostic tools and treatment options. The market methodology involves detailed research and data collection from various primary and secondary sources, ensuring an accurate representation of market dynamics, trends, and future projections. The analysis encompasses therapeutic and diagnostic segments, providing a holistic view of the market landscape.

๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐จ๐ซ ๐ƒ๐ž๐ฆ๐š๐ง๐: ๐–๐ก๐ข๐œ๐ก ๐‘๐ž๐ ๐ข๐จ๐ง๐ฌ ๐€๐ซ๐ž ๐’๐ก๐จ๐ฐ๐ข๐ง๐  ๐†๐ซ๐จ๐ฐ๐ญ๐ก?

North America holds the largest market share, dominating with 39.5% due to the growing geriatric population and high incidence of Alzheimer's disease. The United States leads the region, driven by significant healthcare expenditure and extensive clinical trials. Europe and Asia-Pacific follow, with increasing investments in healthcare infrastructure and rising awareness about early diagnosis and treatment. Emerging markets in Latin America, the Middle East, and Africa also show promising growth due to improved medical facilities and government initiatives.

๐†๐ž๐ญ ๐˜๐จ๐ฎ๐ซ ๐…๐ซ๐ž๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ + ๐•๐ข๐ฌ๐ฎ๐š๐ฅ๐ฌ ๐‡๐ž๐ซ๐ž: https://www.maximizemarketresearch.com/request-sample/116921/

๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง:

The market is segmented into therapeutics and diagnostics. In therapeutics, Cholinesterase inhibitors are expected to dominate due to their effectiveness in managing symptoms of Alzheimer's. These inhibitors are crucial for treating memory, thinking, language, and other cognitive processes. The diagnostics segment is led by Cerebrospinal Fluid (CSF) tests and brain imaging techniques like CT and MRI. These methods are essential for early detection and monitoring of disease progression.

๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ

โ™ฆ Cholinesterase Inhibitors: Largest market share due to efficacy in delaying cognitive decline.
โ™ฆ NMDA Receptor Antagonists: Used for treating moderate to severe Alzheimer's.
โ™ฆ Others: Various emerging treatments under research and development.

๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ๐ฌ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ

โ™ฆ Brain Imaging: Utilizes CT and MRI for diagnostic purposes.
โ™ฆ CFS Tests for Alzheimer's Diseases: Dominates due to the ability to evaluate concentrations of substrates and cells in CSF, aiding in diagnosis.

๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ:

Several key players dominate the Alzheimer's Disease Diagnostic Market, including:

Eli Lilly and Company
TauRx
Alector LLC
Accera, Inc.
Treventis Corporation
Neuro-Bio Ltd
Cognition Therapeutics Inc
Hoffmann-La Roche
Novartis AG
Merck & Co.
Pfizer Inc.
Allergan PLC
Daiichi Sankyo Co.

These companies are heavily investing in research and development to innovate new diagnostic methods and treatments, further propelling market growth.

๐‚๐จ๐ง๐œ๐ฅ๐ฎ๐ฌ๐ข๐จ๐ง:

The Alzheimer's Disease Diagnostic Market is poised for significant growth, driven by the increasing prevalence of the disease and advancements in diagnostic technologies. With North America leading the charge, other regions are also catching up due to improved healthcare infrastructure and rising awareness. The market segmentation highlights key therapeutic and diagnostic tools that are crucial for managing and diagnosing Alzheimer's. Key players in the market continue to push boundaries, ensuring better diagnostic and treatment options for the future.

๐†๐š๐ข๐ง ๐•๐š๐ฅ๐ฎ๐š๐›๐ฅ๐ž ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ: https://www.maximizemarketresearch.com/market-report/global-alzheimers-disease-diagnostic-market/116921/

๐“๐š๐›๐ฅ๐ž ๐จ๐Ÿ ๐‚๐จ๐ง๐ญ๐ž๐ง๐ญ: ๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ ๐Œ๐š๐ซ๐ค๐ž๐ญ

Part 01: Executive Summary A concise overview of the Alzheimer's Disease Diagnostic market, highlighting key insights and main findings.
Part 02: Scope of the Alzheimer's Disease Diagnostic Market Report An outline of the report's coverage, including the objectives, market segments, and data sources used.
Part 03: Alzheimer's Disease Diagnostic Market Landscape A comprehensive analysis of the current market conditions, competitive dynamics, and significant developments.
Part 04: Alzheimer's Disease Diagnostic Market Sizing An in-depth assessment of the market size, including historical data, current figures, and future projections.
Part 05: Alzheimer's Disease Diagnostic Market Segmentation by Type Detailed segmentation of the market based on different types, including analysis and comparisons.
Part 06: Five Forces Analysis An evaluation of the market using Porter's Five Forces framework to understand the competitive intensity.
Part 07: Customer Landscape Insights into the customer demographics, preferences, and purchasing behavior within the market.
Part 08: Geographic Landscape A breakdown of the market by geographical regions, highlighting regional performance and opportunities.
Part 09: Decision Framework Guidelines and criteria for making strategic decisions in the market context.
Part 10: Drivers and Challenges Identification and analysis of the key factors driving market growth and the main challenges faced.
Part 11: Market Trends An exploration of the emerging trends and innovations shaping the future of the market.
Part 12: Vendor Landscape An overview of the competitive landscape, including key vendors, their market share, and strategic initiatives.
Part 13: Vendor Analysis A detailed analysis of major vendors, including their strengths, weaknesses, and competitive strategies.

๐Š๐ž๐ฒ ๐ช๐ฎ๐ž๐ฌ๐ญ๐ข๐จ๐ง๐ฌ ๐š๐ง๐ฌ๐ฐ๐ž๐ซ๐ž๐ ๐ข๐ง ๐ญ๐ก๐ž ๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ'๐ฌ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐š๐ซ๐ž:

โ€ข What is Alzheimer's Disease Diagnostic?
โ€ข What was the Alzheimer's Disease Diagnostic market size in 2023?
โ€ข What is the growth rate of the Alzheimer's Disease Diagnostic Market?
โ€ข Who are the key players in the Alzheimer's Disease Diagnostic market?
โ€ข Who are the leading companies and what are their portfolios in Alzheimer's Disease Diagnostic Market?
โ€ข What are the recent industry trends that can be implemented to generate additional revenue streams for the Alzheimer's Disease Diagnostic Market?
โ€ข Which are the factors expected to drive the Alzheimer's Disease Diagnostic market growth?
โ€ข What are the different segments of the Alzheimer's Disease Diagnostic Market?
โ€ข What growth strategies are the players considering to increase their presence in Alzheimer's Disease Diagnostic?
โ€ข What are the upcoming industry applications and trends for the Alzheimer's Disease Diagnostic Market?
โ€ข What segments are covered in the Alzheimer's Disease Diagnostic Market?
โ€ข What segments are covered in the Alzheimer's Disease Diagnostic Market?
โ€ข What are the key opportunities in the market?
โ€ข What factors restrain the market growth?

๐Š๐ž๐ฒ ๐Ž๐Ÿ๐Ÿ๐ž๐ซ๐ข๐ง๐ ๐ฌ:

โ€ข Past Market Size and Competitive Landscape (2018 to 2022)
โ€ข Past Pricing and price curve by region (2018 to 2022)
โ€ข Market Size, Share, Size & Forecast by Different Segment | 2023-2030
โ€ข Market Dynamics - Growth Drivers, Restraints, Opportunities, and Key Trends by Region
โ€ข Market Segmentation - A detailed analysis by segment with their sub-segments and Region
โ€ข Competitive Landscape - Profiles of selected key players by region from a strategic perspective
o Competitive landscape - Market Leaders, Market Followers, Regional player
o Competitive benchmarking of key players by region
โ€ข PESTLE Analysis
โ€ข PORTER's analysis
โ€ข Value chain and supply chain analysis
โ€ข Legal Aspects of Business by Region
โ€ข Lucrative business opportunities with SWOT analysis
โ€ข Recommendations

๐„๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ž ๐Œ๐จ๐ซ๐ž ๐ˆ๐ง-๐ƒ๐ž๐ฉ๐ญ๐ก ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐จ๐ง ๐‘๐ž๐ฅ๐š๐ญ๐ž๐ ๐“๐จ๐ฉ๐ข๐œ๐ฌ:

1. Reverse Osmosis Membrane Market https://www.maximizemarketresearch.com/market-report/reverse-osmosis-membrane-market/221749/

3. Smart Dust Market https://www.maximizemarketresearch.com/market-report/smart-dust-market/222000/

4. Capacitor Bank Market https://www.maximizemarketresearch.com/market-report/capacitor-bank-market/222051/

5. Satellite Ground Station Market https://www.maximizemarketresearch.com/market-report/satellite-ground-station-market/222057/

6. Online Doctor Consultation Market https://www.maximizemarketresearch.com/market-report/online-doctor-consultation-market/222326/

7. UK Dental Services Market https://www.maximizemarketresearch.com/market-report/uk-dental-services-market/222401/

8. Dropshipping Market https://www.maximizemarketresearch.com/market-report/dropshipping-market/222507/

9. Cider Market https://www.maximizemarketresearch.com/market-report/global-cider-market/27300/

10. Satellite Internet Market https://www.maximizemarketresearch.com/market-report/satellite-internet-market/125907/

๐Ž๐ฎ๐ซ ๐€๐๐๐ซ๐ž๐ฌ๐ฌ:

MAXIMIZE MARKET RESEARCH PVT. LTD.
โฎ 3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
โœ† +91 9607365656
๐Ÿ–‚ sales@maximizemarketresearch.com
๐ŸŒ www.maximizemarketresearch.com

๐€๐›๐จ๐ฎ๐ญ ๐Œ๐š๐ฑ๐ข๐ฆ๐ข๐ณ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Alzheimer's Disease Diagnostic Market Projected to Reach Nearly US$ 8.07 Billion by 2030, Growing at a CAGR of 12.8% here

News-ID: 3556416 • Views: โ€ฆ

More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.

Lab Grown Diamonds Market to Reach USD 57.95 Billion by 2032, Growing at 9.4% CAGR
11-18-2025 | Advertising, Media Consulting, โ€ฆ
MAXIMIZE MARKET RESEARCH PVT. LTD.
Lab Grown Diamonds Market to Reach USD 57.95 Billion by 2032, Growing at 9.4% CA โ€ฆ
According to a new report by Maximize Market Research, the global Lab Grown Diamonds Market was valued at USD 28.24 Billion in 2024 and is projected to reach USD 57.95 Billion by 2032, growing at a CAGR of 9.4%. The market expansion is fueled by increasing consumer preference for sustainable, affordable alternatives to natural diamonds and technological innovations in manufacturing. โ–บ Get a sample of the report:https://www.maximizemarketresearch.com/request-sample/193972/ โ™ฆ Key HighlightsaMarket Size: Market Size:โ€ฆ
Water Quality Sensor Market to Reach USD 11.29 Billion by 2032, Growing at a 4% CAGR
11-18-2025 | Advertising, Media Consulting, โ€ฆ
MAXIMIZE MARKET RESEARCH PVT. LTD.
Water Quality Sensor Market to Reach USD 11.29 Billion by 2032, Growing at a 4% โ€ฆ
According to a new report by Maximize Market Research, the global Water Quality Sensor Market was valued at USD 6.1 Billion in 2024 and is projected to reach USD 11.29 Billion by 2032, growing at a CAGR of 4% during 2025-2032. The market growth is driven by the increasing adoption of smart water monitoring systems, stringent environmental regulations, and demand for real-time water quality assessment across industrial, residential, and governmentalโ€ฆ
E-House Market to Reach USD 3.05 Billion by 2032, Growing at a CAGR of 7.03% | E-House Market Forecast
11-18-2025 | Advertising, Media Consulting, โ€ฆ
MAXIMIZE MARKET RESEARCH PVT. LTD.
E-House Market to Reach USD 3.05 Billion by 2032, Growing at a CAGR of 7.03% | E โ€ฆ
According to a new report by Maximize Market Research, the global E-House Market was valued at USD 1.77 Billion in 2024 and is projected to reach USD 3.05 Billion by 2032, growing at a CAGR of 7.03%. The market growth is driven by the increasing adoption of pre-assembled, modular electrical houses across industrial, renewable energy, and utility sectors worldwide. โ–บ Get a sample of the report:https://www.maximizemarketresearch.com/request-sample/28068/ โ™ฆ Key HighlightsaMarket Size: Market Size: USDโ€ฆ
Global Wind Turbine Inspection Services Market to Reach USD 86.22 Billion by 2032, Growing at 11.7% CAGR
11-18-2025 | Advertising, Media Consulting, โ€ฆ
MAXIMIZE MARKET RESEARCH PVT. LTD.
Global Wind Turbine Inspection Services Market to Reach USD 86.22 Billion by 203 โ€ฆ
According to a new report by Maximize Market Research, the global Wind Turbine Inspection Services Market was valued at USD 35.58 billion in 2024 and is projected to reach USD 86.22 billion by 2032, growing at a CAGR of 11.7%. The market growth is fueled by increasing wind power capacity installations worldwide and the adoption of advanced inspection technologies, including drones, AI, and robotics. โ–บ Get a sample of the report:https://www.maximizemarketresearch.com/request-sample/77606/ โ™ฆโ€ฆ

All 5 Releases


More Releases for Alzheimer

11-17-2025 | Health & Medicine
Exactitude Consultancy
Alzheimer Therapeutics Market Breakthrough Innovations and Increasing Treatment โ€ฆ
The Alzheimer Therapeutics Market is rapidly evolving as disease-modifying therapies, early-stage diagnostic tools, and biomarker-driven treatment approaches reshape global management of Alzheimer's disease (AD). As one of the most prevalent neurodegenerative conditions, Alzheimer's affects millions of older adults worldwide. With recent regulatory approvals of anti-amyloid monoclonal antibodies, enhanced imaging technology, and increased R&D investment, the market is experiencing unprecedented momentum. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/51928 Key Takeaways โ€ข Disease-modifyingโ€ฆ
11-26-2024 | Health & Medicine
Data Bridge Market Research
Dementia - Alzheimer Disease Market: A Comprehensive Analysis 2030
Dementia and Alzheimer's disease represent significant challenges within the global healthcare sector. These neurological disorders, characterized by progressive cognitive decline, have seen increasing prevalence due to aging populations worldwide. This growing burden has spurred interest in the Dementia - Alzheimer's disease market, encompassing diagnostic tools, treatments, caregiving solutions, and related healthcare services. This article provides an overview of the market, its scope, current trends, and factors driving its expansion. Data Bridgeโ€ฆ
08-22-2023 | Advertising, Media Consulting, โ€ฆ
Dhirtek Business Research and Consulting
Alzheimer Disease Treatment Market | Allergan, Amgen, Daiichi Sankyo, Eisai
The global alzheimer disease treatment market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the alzheimer disease treatment market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growthโ€ฆ
05-31-2023 | Health & Medicine
Cognate Life Sciences
United States Alzheimer Drugs Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "United States Alzheimer Drugs Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointlyโ€ฆ
09-13-2021 | Health & Medicine
Ken Research Pvt Ltd
Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe โ€ฆ
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors isโ€ฆ
06-30-2017 | Health & Medicine
PNS Pharma
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimerโ€™s disease was 5.4 million in 2012. Out of this,โ€ฆ